MedPath

ONIVYDE PEGYLATED LIPOSOMAL 4,3 MG/ML CONCENTRADO PARA DISPERSION PARA PERFUSION

ONIVYDE PEGYLATED LIPOSOMAL 4,3 MG/ML CONCENTRADO PARA DISPERSION PARA PERFUSION

Commercialized
Register Number

1161130001

Prescription Type

Uso Hospitalario

Authorization Date

Nov 10, 2016

Dosage Form

CONCENTRADO PARA DISPERSIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1161130001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
Yes
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

IRINOTECANActive
Quantity: 4,3 mg
Name: IRINOTECAN

ATC CLASSIFICATION (3)

L01C
L01CE
L01CE02

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.